Premier Buffer B Reagent 의 안전성 경고

Department of Health에 따르면, 해당 안전성 경고 는 Hong Kong 에서 Trinity Biotech 에 의해 제조된 제품과 관련되어 있습니다.

이것은 무엇인가요?

안전성 경고는 의료기기 제품과 관련된 중요한 정보와 권고사항을 담고 있습니다. 물론 안전성 경고가 배포되었다고 해서 해당 제품이 무조건 안전하지 않은 제품이라는 것은 아닙니다. 보건의료업계 종사자와 의료기기 사용자들에게 배포되는 안전성 경고에는 회수(recall)도 포함될 수 있습니다. 제조사가 안전성 경고를 작성하기도 하지만, 보건당국에서 작성하는 경우도 있습니다.

데이터에 대해 더 자세히 알아보기 여기
  • 사례 유형
    Safety alert
  • 날짜
    2017-06-07
  • 사례 출판 날짜
    2017-06-07
  • 사례 국가
  • 사례 출처
    DH
  • 사례 출처 URL
  • 비고 / 경고
    Hong Kong data is current through September 2018. All of the data comes from the Department of Health (Hong Kong), except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of data from the U.S. and Hong Kong.
  • 데이터 추가 비고
    Medical Device Safety Alert
  • 원인
    Medical device safety alert: trinity biotech premier buffer b reagent medical device manufacturer, trinity biotech, has issued a medical device safety alert concerning its premier buffer b reagent [product code: 01-03-0096 (940 ml); lot number: 6524]. the manufacturer has identified that the closed bottle stability for some bottles of lot 6524 may be reduced due to a broken seal under the cap of unopened bottles. in cases where a broken seal of an unopened bottle is encountered, the open bottle stability is essentially started and the bottle stability performance will be reduced, as it would over time when installed on the premier hb9210 system. where analytical run qc recovery is within range, the performance of the system and results are acceptable. however, if an unopened reagent bottle is found to have a broken seal prior to use, the open bottle stability has started. prior to consumption of the bottle, it may be observed that controls drift out quicker than normal, thereby requiring more frequent calibrations. the qc recovery (controls) verification will identify and contain this issue, as designed and there is no need for review of previously reported results. a thorough investigation into the root cause has been conducted and no other lots are affected. to avoid need for extra control runs and calibrations, the manufacturer recommends: discontinue the use of the above reagent lots. destroy any remaining product. notify all end-users of this notification. product replacement is on-going. according to the local supplier, the affected products are distributed in hong kong if you are in possession of the affected products, please contact your supplier for necessary actions. posted on 7 june 2017.

Device

  • 모델명 / 제조번호(시리얼번호)
  • 제품 설명
    Medical Device Safety Alert: Trinity Biotech Premier Buffer B Reagent
  • Manufacturer

Manufacturer